These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 5840572)

  • 21. Antioxidant potential in esophageal, stomach and colorectal cancers.
    Skrzydlewska E; Kozuszko B; Sulkowska M; Bogdan Z; Kozlowski M; Snarska J; Puchalski Z; Sulkowski S; Skrzydlewski Z
    Hepatogastroenterology; 2003; 50(49):126-31. PubMed ID: 12630007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fractionation of toxohormone with calcium phosphate gel.
    Hozumi M; Ohashi M; Ono T
    Gan; 1965 Jun; 56(3):313-5. PubMed ID: 5831712
    [No Abstract]   [Full Text] [Related]  

  • 23. [Modifications of catalase activity in the blood and liver punctates in cancer and precancer of the stomach; preliminary communication].
    BRAMBERGA VM
    Vopr Klin Lecheniia Zlokachestvennykh Novoobraz; 1956; 4():205-7. PubMed ID: 13468313
    [No Abstract]   [Full Text] [Related]  

  • 24. Differential expression of manganese superoxide dismutase, copper/zinc superoxide dismutase, and catalase in gastric adenocarcinoma and normal gastric mucosa.
    Hwang TS; Choi HK; Han HS
    Eur J Surg Oncol; 2007 May; 33(4):474-9. PubMed ID: 17129702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of the MAGE gene family in human gastric carcinoma.
    Li J; Yang Y; Fujie T; Tanaka F; Mimori K; Haraguchi M; Ueo H; Mori M; Akiyoshi T
    Anticancer Res; 1997; 17(5A):3559-63. PubMed ID: 9413202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purification and characterization of a lipolytic factor (toxohormone-L) from cell-free fluid of ascites sarcoma 180.
    Masuno H; Yamasaki N; Okuda H
    Cancer Res; 1981 Jan; 41(1):284-8. PubMed ID: 7448767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Studies of toxohormones and neoplasms].
    Fujii S; Akiyoshi H; Shirasaka T
    Nihon Rinsho; 1976 May; 34(5):1066-73. PubMed ID: 988235
    [No Abstract]   [Full Text] [Related]  

  • 29. [Secretory activity of neoplastic tissue].
    Zimel H
    Stud Cercet Endocrinol; 1971; 22(5):385-7. PubMed ID: 5141802
    [No Abstract]   [Full Text] [Related]  

  • 30. Biochemical studies on the liver catalase depressing factor of toxohormone.
    OKAMURA Y
    Kyushu J Med Sci; 1962 Dec; 13():299-311. PubMed ID: 13939793
    [No Abstract]   [Full Text] [Related]  

  • 31. [An electrophoretic analysis of the tumor and blood proteins in stomach cancer].
    Gnatyshak AI; Sukhomlinov BF; Kordoba MT; Savran VR
    Vopr Onkol; 1969; 15(11):28-32. PubMed ID: 5368837
    [No Abstract]   [Full Text] [Related]  

  • 32. [Synthesis and phosphorylation of gastric proteins in cells of human gastric carcinoma].
    Karakin EI; Nepomniashchikh LM; Vardosanidze KV; Nekarda J; Patiutko IuI; Nepomniashchikh GI; Suderevskiĭ EA; Nechunaev VV; Adon'eva NV; Cheresiz SV; Bochkarev MN
    Biull Eksp Biol Med; 1996 Jun; 121(6):676-81. PubMed ID: 9035765
    [No Abstract]   [Full Text] [Related]  

  • 33. [Liver catalase and liver non-hemin iron in gastric cancer].
    SASORI T
    Gan; 1956 Dec; 47(3-4):294-5. PubMed ID: 13415007
    [No Abstract]   [Full Text] [Related]  

  • 34. Oxidative stress and antioxidants status in peptic ulcer and gastric carcinoma.
    Tandon R; Khanna HD; Dorababu M; Goel RK
    Indian J Physiol Pharmacol; 2004 Jan; 48(1):115-8. PubMed ID: 15270379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concentration-dependent collateral sensitivity of cisplatin-resistant gastric cancer cell sublines.
    Xu H; Choi SM; An CS; Min YD; Kim KC; Kim KJ; Choi CH
    Biochem Biophys Res Commun; 2005 Mar; 328(2):618-22. PubMed ID: 15694393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxohormone in bacteria-free tumors.
    Nixon JC; Zinman B
    Can J Biochem; 1966 Aug; 44(8):1069-87. PubMed ID: 5968598
    [No Abstract]   [Full Text] [Related]  

  • 37. Purification of toxohormone by DEAE-cellulose columnchromatography.
    OHASHI M; ONO T
    Gan; 1959 Dec; 50():347-57. PubMed ID: 14428444
    [No Abstract]   [Full Text] [Related]  

  • 38. [mRNA expression of IGF-IIand HGF in relation to microvascular density, tumor progression and prognosis of gastric carcinoma].
    Zhao ZS; Ru GQ; Ma J
    Zhonghua Zhong Liu Za Zhi; 2004 Nov; 26(11):673-7. PubMed ID: 15777506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Composition and properties of a highly purified toxohormone preparation.
    YUNOKI K; GRIFFIN AC
    Cancer Res; 1961 May; 21():537-44. PubMed ID: 13787560
    [No Abstract]   [Full Text] [Related]  

  • 40. Serum hepatocyte growth factor level associate with gastric cancer progression.
    Wu CW; Chi CW; Su TL; Liu TY; Lui WY; P'eng FK
    Anticancer Res; 1998; 18(5B):3657-9. PubMed ID: 9854473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.